Iodixanol-associated acute kidney injury and prognosis in patients undergoing elective percutaneous coronary intervention: a prospective, multi-center study.
Zaiyan ChenQi MaoLi XiangDenglu ZhouYanbing JiangNing ZhaoLan HuangLorenzo AzzaliniXiao-Hui ZhaoPublished in: European radiology (2023)
• The incidence of iodixanol-associated acute kidney injury was low and mostly limited to mild renal impairment. • Iodixanol administration had no statistically significant impact on the major adverse renal and cardiovascular events in patients undergoing elective percutaneous coronary intervention.
Keyphrases
- patients undergoing
- acute kidney injury
- percutaneous coronary intervention
- cardiovascular events
- coronary artery disease
- st segment elevation myocardial infarction
- cardiac surgery
- st elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery bypass grafting
- cardiovascular disease
- atrial fibrillation
- risk factors
- emergency department
- type diabetes